bioAffinity Technologies BIAF
NASDAQ BIAF
$6.56 -0.32 (-4.65%)
At close: Sep 30, 2026 · 4:00 PM EDT

bioAffinity Technologies (BIAF) Convertible Debt (2021 - 2022)

Updated

bioAffinity Technologies (BIAF) recorded Convertible Debt of $325,000 in Q4 2022, down 87.5% from $2.6 million a year earlier and down 87.5% from the prior quarter.

Analysis

bioAffinity Technologies (BIAF) Convertible Debt (2021 - 2022) Analysis & Trends

Starting with Q3 2021, bioAffinity Technologies' Convertible Debt history includes 5 quarters.

  • Across earlier years, Convertible Debt came in at $2.6 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 93.06 Bn 92.50 Bn -
2 Natera 59.36 Bn 55.04 Bn 485.19 Mn
3 Quest Diagnostics 25.72 Bn 24.15 Bn 1.03 Bn
4 Labcorp Holdings 24.93 Bn 22.69 Bn 1.11 Bn
5 Guardant Health 23.83 Bn 19.89 Bn 219.03 Mn
6 Tenet Healthcare 20.58 Bn 11.72 Bn -
7 Tempus AI 14.35 Bn 11.38 Bn 246.50 Mn
8 Encompass Health 11.99 Bn 12.46 Bn -
9 BrightSpring Health Services 11.21 Bn 9.55 Bn 492.75 Mn
10 bioAffinity Technologies 2.29 Mn -17.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 325,000.00
Sep 30, 2022 2.60 Mn
Mar 31, 2022 2.60 Mn
Dec 31, 2021 2.60 Mn
Sep 30, 2021 900,000.00
API Access

bioAffinity Technologies Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=BIAF&period=max&api_key=YOUR_API_KEY